1. Home
  2. CYTK vs EXP Comparison

CYTK vs EXP Comparison

Compare CYTK & EXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$56.27

Market Cap

7.8B

Sector

Health Care

ML Signal

N/A

Logo Eagle Materials Inc

EXP

Eagle Materials Inc

N/A

Current Price

$180.71

Market Cap

7.0B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
EXP
Founded
1997
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
7.0B
IPO Year
2004
1994

Fundamental Metrics

Financial Performance
Metric
CYTK
EXP
Price
$56.27
$180.71
Analyst Decision
Buy
Hold
Analyst Count
22
11
Target Price
$109.42
★ $195.10
AVG Volume (30 Days)
★ 1.9M
404.6K
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
★ 0.55%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 6.91
Revenue
$13,368,000.00
★ $495,023,000.00
Revenue This Year
$87.17
$1.01
Revenue Next Year
$170.90
$2.39
P/E Ratio
★ N/A
$26.39
Revenue Growth
N/A
★ N/A
52 Week Low
$53.58
$160.02
52 Week High
$88.31
$245.53

Technical Indicators

Market Signals
Indicator
CYTK
EXP
Relative Strength Index (RSI) 38.80 48.42
Support Level N/A $173.89
Resistance Level $66.62 $222.22
Average True Range (ATR) 2.69 6.92
MACD -0.24 -0.29
Stochastic Oscillator 24.29 26.46

Price Performance

Historical Comparison
CYTK
EXP

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About EXP Eagle Materials Inc

Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.

Share on Social Networks: